AMP Ameriprise Financial Inc

Allspring Global Investments Holdings LLC reduced its stake in Arch Capital Group Ltd. by 16.8% in the third quarter, selling 761,906 shares and now owning 3,771,627 shares valued at $340.6 million. This reduction comes amid significant insider selling, with executives offloading 220,666 shares worth $20.7 million in the past 90 days. Despite strong Q3 earnings, analyst opinions are mixed, with a consensus "Hold" rating and a target price of $106.00.

Sirius XM Holdings Inc. (NASDAQ:SIRI) experienced unusually high call option trading volume, with investors purchasing 41,683 call options, a 261% increase over the typical daily volume. This surge in bullish options activity follows institutional accumulation by Berkshire Hathaway and others, and the company maintains a quarterly dividend of $0.27, yielding approximately 5.3%. Analysts have a consensus "Hold" rating on the stock with an average price target of $24.29.

Harbor Capital Advisors Inc. significantly reduced its stake in Knife River Corporation ($KNF) by selling 89.3% of its shares, decreasing its holdings to 4,402 shares valued at $338,000. Conversely, several other institutional investors, including Norges Bank, Ameriprise Financial, Raymond James Financial, Franklin Resources, and Boston Partners, either initiated new positions or substantially increased their holdings in KNF. Analysts have a "Moderate Buy" rating for Knife River, with an average price target of $96.33, while the stock currently trades around $72.64.

Ergawealth Advisors Inc. significantly reduced its stake in First Trust Capital Strength ETF ($FTCS) by 24.5% in the third quarter, now owning 121,518 shares worth $11.379 million. Despite this, other firms like Goldman Sachs Group Inc. and Bank of America Corp DE increased their holdings in the ETF. The First Trust Capital Strength ETF recently declared a quarterly dividend of $0.2607, representing an annualized dividend of $1.04 and a yield of 1.1%.

Abacus FCF Advisors LLC has reduced its stake in Gilead Sciences, Inc. by 16.0%, selling 26,340 shares but still holding 138,674 shares valued at $15.39 million. Despite this reduction, Gilead remains the firm's 24th largest holding. Concurrently, other institutions like Norges Bank and Ameriprise Financial Inc. have significantly increased their positions in the biopharmaceutical company, bringing institutional ownership to approximately 83.67%.

Suvretta Capital Management, L, a director of Benitec Biopharma (NASDAQ:BNTC), recently purchased 77,387 shares of the company's stock at an average price of $13.44, totaling over $1.04 million. This acquisition increases their stake to 9,700,195 shares, representing a 0.80% ownership increase. This transaction is part of a series of recent purchases by Suvretta Capital, indicating significant insider accumulation and reflecting their confidence in the biotechnology company.